NASDAQ · Healthcare · Biotechnology
Arcutis Biotherapeutics, Inc.
ARQT
Arcutis Biotherapeutics, Inc. CEO Todd Franklin Watanabe · Market cap $2.7B.
$21.40
+0.71 · +3.43%
52w hi $31.7752w lo $12.72
Off 52w high 28.1%
40
ROUTINE
Current InsiderScore
Corp · 90d
0
0 buys · 0 sales
Cong · 90d
1
1 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
Avg PT $33.33
Section 01
Recent Form 4 filings
8 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 13 | Patrick J Heron | Buy | 2,646 | $13.08 | +$35K | 37 | |
| Jun 04 | Patrick J Heron | Buy | 1,890 | $13.32 | +$25K | 34 | |
| May 22 | Patrick J Heron | Buy | 2,520 | $13.65 | +$34K | 37 | |
| May 21 | Patrick J Heron | Buy | 2,520 | $13.66 | +$34K | 37 | |
| May 15 | Patrick J Heron | Buy | 2,520 | $13.62 | +$34K | 37 | |
| May 14 | Patrick J Heron | Buy | 6,300 | $13.76 | +$87K | 60 | |
| May 13 | Patrick J Heron | Buy | 2,374 | $13.76 | +$33K | 55 | |
| May 09 | Patrick J Heron | Buy | 6,300 | $13.60 | +$86K | 60 |
Section 02
Recent STOCK Act disclosures
1 disclosures on file
| Disclosed | Legislator | Chamber · State | Action | Range | Midpoint | Delay | Score |
|---|---|---|---|---|---|---|---|
| Apr 08 | Gilbert Cisneros | House · CA | Buy | $1,001 - $15,000 | $8K | 36 d | 40 |
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay